Deterioration in business performance due to prolonged product development and quality defects
First written in FY2016. 9 of 10 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2026: 11 of 57 companies on the "Worse" side.
125 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「However, developing products that meet customer needs can result in product development taking a considerable amount of time. In addition, new technologies or ingredients may be developed or discovered after a product is launched, which could prevent us from achieving the expected profit.」
The company is reaffirming the risk of failing to achieve expected profits due to prolonged product development and the discovery after launch of new technologies or ingredients. - FY2023RestatedAnnual report
「However, developing products that meet customer needs can result in product development taking a considerable amount of time. In addition, new technologies or ingredients may be developed or discovered after a product is launched, which could prevent us from achieving the expected profit.」
The company is reaffirming the risk of failing to achieve expected profits due to prolonged product development and the discovery after launch of new technologies or ingredients. - FY2022RestatedAnnual report
「However, developing products that meet customer needs can result in product development taking a considerable amount of time. In addition, new technologies or ingredients may be developed or discovered after a product is launched, which could prevent us from achieving the expected profit.」
The company is reaffirming the risk of deterioration in operating performance due to prolonged product development, the discovery after launch of new technologies or ingredients, and quality defects. - FY2021-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year under review, there were no newly arising business or other risks. There were also no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes concerning the risk of deterioration in operating performance due to prolonged product development and quality defects. - FY2021-Q2RestatedAnnual report
「During the cumulative consolidated period for the second quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no material changes concerning the risk of deterioration in operating performance due to prolonged product development and quality defects. - FY2020-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year under review, there were no newly arising business or other risks. There were also no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes concerning the risks arising from prolonged product development and quality defects. - FY2019RestatedAnnual report
「Research and development of products is one of the pillars of our Group's growth, and we will continue to launch new and renewed products. However, developing products that meet customer needs can result in product development taking a considerable amount of time.」
The company reiterates the risk of deterioration in operating performance due to prolonged product development, the discovery after launch of new technologies or ingredients, and quality defects. - FY2018RestatedAnnual report
「Research and development of products is one of the pillars of our Group's growth, and we will continue to launch new and renewed products. However, developing products that meet customer needs can result in product development taking a considerable amount of time.」
The company reiterates the risk of deterioration in operating performance due to prolonged product development, the discovery after launch of new technologies or ingredients, and quality defects. - FY2017RestatedAnnual report
「Research and development of products is one of the pillars of our Group's growth, and we will continue to launch new and renewed products. However, developing products that meet customer needs can result in product development taking a considerable amount of time.」
The company reiterates the risks of prolonged product development, the discovery after launch of new technologies or ingredients, and quality defects. - FY2016First statedAnnual report
「Research and development of products is one of the pillars of our Group's growth, and we will continue to launch new and renewed products. However, developing products that meet customer needs can result in product development taking a considerable amount of time.」
The company anticipates risks from prolonged development, the discovery after launch of new technologies or ingredients, and losses caused by product defects.